StemExpress Signs Distribution Agreement with CliniSciences

FOLSOM, CA - Sep 26, 2017 - StemExpress is a premier provider of human blood-derived cell products, including bone marrow, cord blood, peripheral blood, Leukopaks®, Mobilized Leukopaks, and primary cells. To continue meeting the needs of clients abroad, StemExpress has expanded its global capabilities to Europe through a distribution agreement with CliniSciences, a supplier of research and in-vitro  diagnostic products, that pride themselves in delivering adaptability, flexibility, and reactivity to their customers.

This partnership ensures that international researchers have quick access to StemExpress’ high-quality fresh and cryopreserved hematopoietic products with easily accessible customer service and technical support in their native language from CliniSciences. A complete list of CliniSciences locations and contact information can be found at https://www.stemexpress.com/about/distributors/. 

About StemExpress

StemExpress is a life-science company dedicated to advancing medical science. Since 2010, we have supported researchers globally by offering human blood-derived cell products, including whole blood and primary cells. We source bone marrow, cord blood, peripheral blood, Leukopaks and Mobilized Leukopaks from our own strategically located collection centers. We provide expediency from order to delivery and guarantee every sample arrives with the highest purity, viability, and quality researchers need to ensure confidence in their results.

For more information, please visit www.stemexpress.com or follow the company on LinkedIn at https://www.linkedin.com/company/2224461/.